These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 22931186)
21. Population pharmacokinetics of liposomal amphotericin B in pediatric patients with malignant diseases. Hong Y; Shaw PJ; Nath CE; Yadav SP; Stephen KR; Earl JW; McLachlan AJ Antimicrob Agents Chemother; 2006 Mar; 50(3):935-42. PubMed ID: 16495254 [TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic properties of infliximab in children and adults with Crohn's disease: a retrospective analysis of data from 2 phase III clinical trials. Fasanmade AA; Adedokun OJ; Blank M; Zhou H; Davis HM Clin Ther; 2011 Jul; 33(7):946-64. PubMed ID: 21741088 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic behavior and appraisal of intravenous busulfan dosing in infants and older children: the results of a population pharmacokinetic study from a large pediatric cohort undergoing hematopoietic stem-cell transplantation. Paci A; Vassal G; Moshous D; Dalle JH; Bleyzac N; Neven B; Galambrun C; Kemmel V; Abdi ZD; Broutin S; Pétain A; Nguyen L Ther Drug Monit; 2012 Apr; 34(2):198-208. PubMed ID: 22406655 [TBL] [Abstract][Full Text] [Related]
24. Population pharmacokinetics of intravenous bolus etomidate in children over 6 months of age. Lin L; Zhang JW; Huang Y; Bai J; Cai MH; Zhang MZ Paediatr Anaesth; 2012 Apr; 22(4):318-26. PubMed ID: 21917057 [TBL] [Abstract][Full Text] [Related]
25. Population pharmacokinetics of rifampicin in Mexican patients with tuberculosis. Milán Segovia RC; Domínguez Ramírez AM; Jung Cook H; Magaña Aquino M; Vigna Pérez M; Brundage RC; Romano Moreno S J Clin Pharm Ther; 2013 Feb; 38(1):56-61. PubMed ID: 23167603 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic evaluation of the vinorelbine-lapatinib combination in the treatment of breast cancer patients. Rezai K; Urien S; Isambert N; Roche H; Dieras V; Berille J; Bonneterre J; Brain E; Lokiec F Cancer Chemother Pharmacol; 2011 Dec; 68(6):1529-36. PubMed ID: 21519841 [TBL] [Abstract][Full Text] [Related]
27. A population pharmacokinetic/pharmacodynamic model of methotrexate and mucositis scores in osteosarcoma. Johansson ÅM; Hill N; Perisoglou M; Whelan J; Karlsson MO; Standing JF Ther Drug Monit; 2011 Dec; 33(6):711-8. PubMed ID: 22105588 [TBL] [Abstract][Full Text] [Related]
28. ABCB1 C3435T genetic polymorphism on population pharmacokinetics of methotrexate after hematopoietic stem cell transplantation in Korean patients: a prospective analysis. Kim IW; Yun HY; Choi B; Han N; Park SY; Lee ES; Oh JM Clin Ther; 2012 Aug; 34(8):1816-26. PubMed ID: 22796246 [TBL] [Abstract][Full Text] [Related]
29. Population pharmacokinetics of ciprofloxacin in pediatric patients. Rajagopalan P; Gastonguay MR J Clin Pharmacol; 2003 Jul; 43(7):698-710. PubMed ID: 12856383 [TBL] [Abstract][Full Text] [Related]
30. Population pharmacokinetics of APOMINE: a meta-analysis in cancer patients and healthy males. Bonate PL; Floret S; Bentzen C Br J Clin Pharmacol; 2004 Aug; 58(2):142-55. PubMed ID: 15255796 [TBL] [Abstract][Full Text] [Related]
31. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis. Zhou H; Mayer PR; Wajdula J; Fatenejad S J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of etoposide (VP16) in children and adolescents with refractory solid tumors. Sinkule JA; Hutson P; Hayes FA; Etcubanas E; Evans W Cancer Res; 1984 Jul; 44(7):3109-13. PubMed ID: 6539169 [TBL] [Abstract][Full Text] [Related]
33. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy. Chhun S; Jullien V; Rey E; Dulac O; Chiron C; Pons G Epilepsia; 2009 May; 50(5):1150-7. PubMed ID: 19175400 [TBL] [Abstract][Full Text] [Related]
34. Dexmedetomidine pharmacokinetics in pediatric intensive care--a pooled analysis. Potts AL; Anderson BJ; Warman GR; Lerman J; Diaz SM; Vilo S Paediatr Anaesth; 2009 Nov; 19(11):1119-29. PubMed ID: 19708909 [TBL] [Abstract][Full Text] [Related]
35. Population pharmacokinetic analysis of meropenem in Japanese adult patients. Muro T; Sasaki T; Hosaka N; Umeda Y; Takemoto S; Yamamoto H; Kamimura H; Higuchi S; Karube Y J Clin Pharm Ther; 2011 Apr; 36(2):230-6. PubMed ID: 21366653 [TBL] [Abstract][Full Text] [Related]
36. Physiologically based pharmacokinetic modelling of high- and low-dose etoposide: from adults to children. Kersting G; Willmann S; Würthwein G; Lippert J; Boos J; Hempel G Cancer Chemother Pharmacol; 2012 Feb; 69(2):397-405. PubMed ID: 21789689 [TBL] [Abstract][Full Text] [Related]
37. Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults. Menon-Andersen D; Mondick JT; Jayaraman B; Thompson PA; Blaney SM; Bernstein M; Bond M; Champagne M; Fossler MJ; Barrett JS Cancer Chemother Pharmacol; 2009 Jan; 63(2):229-38. PubMed ID: 18398615 [TBL] [Abstract][Full Text] [Related]
38. Population pharmacokinetics of oxycodone in children 6 months to 7 years old. El-Tahtawy A; Kokki H; Reidenberg BE J Clin Pharmacol; 2006 Apr; 46(4):433-42. PubMed ID: 16554451 [TBL] [Abstract][Full Text] [Related]
39. Population pharmacokinetics of omeprazole in critically ill pediatric patients. Solana MJ; Colom H; López-Herce J; Urbano J; González R; López J; Manzanares C; Carrillo A Ther Drug Monit; 2014 Aug; 36(4):519-27. PubMed ID: 24365987 [TBL] [Abstract][Full Text] [Related]
40. Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients. Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Pandey RK; Tsuchida T; Dougherty TJ Cancer Res; 2003 Apr; 63(8):1806-13. PubMed ID: 12702566 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]